查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983942

异丁酸市场：2026-2032年全球市场预测（依原料、等级、形态、应用及通路划分）

Isobutyric Acid Market by Source, Grade, Form, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，异丁酸市值将达到 2.4679 亿美元，到 2026 年将成长至 2.7058 亿美元，到 2032 年将达到 4.3566 亿美元，年复合成长率为 8.45%。

主要市场统计数据
基准年 2025 2.4679亿美元
预计年份：2026年 2.7058亿美元
预测年份 2032 4.3566亿美元
复合年增长率 (%) 8.45%

对异丁酸进行简明扼要的基本概述：重点在于策略重点、供应侧考量和监管压力，这些因素将影响短期产业选择。

本执行摘要重点概述了异丁酸，整合了其核心工业作用、需求驱动因素以及当前影响商业性决策的永续性和监管方面的考虑。此分子用途广泛，从製剂层面的功能到中间体合成，这意味着生产商和终端用户的策略选择将对整个供应链和应用领域产生连锁反应。因此，经营团队需要一份简洁且技术支撑的概述，以便优先考虑产能投资、原料策略和新产品开发。

永续发展主导的采购、生物基生产的进步以及日益严格的产品规格如何重塑整个供应链的竞争优势。

由于三大因素的共同作用，异丁酸市场格局正在经历一场变革：品牌所有者对永续发展的承诺、绿色化学领域原材料的创新，以及对纯度和来源监管力度的加强。各应用领域的企业对低碳原料和透明供应链的需求日益增长，迫使供应商投资于生物基生产路线、生命週期分析和可认证的可追溯性。同时，催化转化和发酵平台的进步降低了采用可再生原料的技术门槛，但要实现规模和成本上的等效性仍然是一个现实的挑战。

评估美国在 2025 年采取的累积关税措施引发的战略供应链因应措施、采购政策转变和生产系统重组。

美国近期及预期未来关税措施的累积影响，正在引发一系列可衡量的供应链反应，而不仅限于即时的价格波动。受进口关税影响的企业正透过调整筹资策略，转向更多元化的供应商体系，加快供应商认证流程，并在条件允许的情况下寻求近岸外包和本地化生产，以保护自身营运免受贸易政策变化的影响。这些调整也有助于与国内生产商签订长期合同，并进行策略性库存管理，从而降低成本剧烈波动带来的风险。

详细的细分揭示了特定应用规格、生产路线、等级差异、产品形式和分销管道如何决定商业性和技术重点。

细分市场分析揭示了製造商和买家必须同时考虑的不同价值来源和业务需求。从应用领域来看，异丁酸的需求涵盖农业领域（异丁酸是杀菌剂、除草剂和杀虫剂的关键中间体）、食品饮料领域（异丁酸用作酸味剂和香料）、个人保健产品领域（异丁酸的润肤和调味特性被充分利用）以及製药领域（异丁酸作为医药中间体和添加剂，需要严格的品管）。每个应用领域对纯度、文件和物流都有不同的要求，这些要求影响产品规格和商业条件。

美洲、欧洲、中东和非洲以及亚太地区的区域监管要求、原材料供应情况和需求趋势如何重塑供应和合规策略？

区域趋势对供应、监管协调和终端用户需求产生重大影响，进而影响策略规划。在美洲，製造业生态系统受惠接近性大规模农化和製药产业丛集，以及支持产品快速流通的一体化物流网络。然而，这些优势会受到贸易政策和原物料供应波动的影响，因此需要采取对冲性筹资策略。转型为低碳生产是许多北美买家决策的重要因素，导致经认证的生物基产品溢价上涨。

透过结合技术严谨性、灵活的通路和协作生产模式，能够满足规格主导需求的生产商正在获得竞争优势。

异丁酸价值链的竞争动态呈现出多元化的特点，既有特种化学品製造商，也有垂直整合型生产商，还有专注于生物基路线和製程整合的小规模创新企业。行业领导企业透过投资品管系统来确保向製药和食品等受监管行业供应产品，从而脱颖而出；而新兴企业则往往在成本、原材料整合或特定应用领域的专业知识方面展开竞争。策略伙伴关係和合约製造协议已成为管理产能限制、共用技术风险以及加速新生产流程上市速度的常用手段。

高阶主管可采取的行动步骤，以增强供应商的韧性，加快生物基产品的采用，提高监管合规能力，并优化分销和采购计画。

产业领导企业应优先采取一系列切实可行的措施，将新风险转化为策略机会。首要任务是系统化供应商韧性标准，将品管系统、可追溯性和物流冗余纳入其中。采购团队需要超越以价格为中心的指标，并将这些要素纳入合约条款和认证流程。其次，有针对性地投资于中试规模的生物基生产，并与生物技术公司建立合作关係，将有助于建立可持续发展的良好记录，降低长期原材料采购风险，并允许根据技术检验里程碑进行资本配置管理。

为了支持可操作的策略结论，我们采用了严格的混合方法，结合了初步访谈、技术审查、供应链映射和情境分析。

本执行摘要的研究途径融合了多学科见解，以确保观察结果的平衡性和检验。初步研究包括对配方、采购和生产方面的技术负责人进行结构化访谈，以及与製程工程师和法规专家进行讨论，以检验生产路线的权衡和特定等级的要求。这些工作提供了关于营运限制、认证计划和客户验收标准的深入定性见解。

此策略性地整合了技术和商业性要求，为不断变化的异丁酸市场环境中的生产商和买家提供了可靠的路线图。

总之，异丁酸在化学、永续性和监管要求三者交汇处占据着战略地位，这不仅为生产商和买家带来了机会，也带来了营运挑战。对高纯度异丁酸的需求不断增长，人们对生物基生产路线的兴趣日益浓厚，以及主导贸易政策趋势的外部因素，都要求我们重新评估采购标准、产能投资和伙伴关係策略。那些积极整合技术能力、提高供应柔软性并建立健全品管系统的公司，将更有利于规格驱动价值的最大化。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：异丁酸市场：依来源划分

  • 生物衍生
  • 合成

第九章：异丁酸市场：依等级划分

  • 食品级
  • 医药级
    • EP等级
    • 日本等级
    • USP 等级
  • 技术级
    • 工业级
    • 研究级

第十章：异丁酸市场：依形式划分

  • 液体
  • 粉末

第十一章 异丁酸市场：依应用领域划分

  • 杀虫剂
    • 消毒剂
    • 除草剂
    • 杀虫剂
  • 食品/饮料
    • 酸味剂
    • 香料
  • 个人护理
    • 皮肤柔软精
    • 香味
  • 製药
    • 医药中间体
    • 添加剂

第十二章 异丁酸市场：依通路划分

  • 直销
  • 销售代理
    • 零售
    • 批发商
  • 线上管道
    • 企业网站
    • 电子商务平台

第十三章 异丁酸市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 异丁酸市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 异丁酸市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国异丁酸酯市场

第十七章：中国异丁酸市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AFYREN SA
  • Arkema Group
  • BASF SE
  • Central Drug House
  • Chemos GmbH
  • Daicel Corporation
  • Dow Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Glentham Life Sciences Limited
  • INEOS Group Limited
  • Jiangsu Dynamic Chemical Co., Ltd.
  • Lygos, Inc.
  • LyondellBasell Industries NV
  • Merck KGaA
  • Mitsubishi Chemical Corporation
  • Nanjing Chemical Material Corporation
  • Perstorp Holding AB
  • Sasol Limited
  • Shanghai Aladdin Biochemical Technology Co., Ltd.
  • Sigma-Aldrich Corporation
  • Snowco Industrial Co., Ltd.
  • Tokyo Chemical Industry Co., Ltd.
  • Wacker Chemie AG
  • Weifang Qiyi Chemical Co., Ltd.
  • Yufeng International Group Co., Ltd.
  • Zhejiang Funai Pharmaceutical Co., Ltd
Product Code: MRR-CF6C60CF95A0

The Isobutyric Acid Market was valued at USD 246.79 million in 2025 and is projected to grow to USD 270.58 million in 2026, with a CAGR of 8.45%, reaching USD 435.66 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 246.79 million
Estimated Year [2026] USD 270.58 million
Forecast Year [2032] USD 435.66 million
CAGR (%) 8.45%

A concise foundational orientation to isobutyric acid revealing strategic priorities, supply considerations, and regulatory pressures shaping near-term industry choices

This executive summary provides a focused orientation to isobutyric acid, synthesizing its core industrial roles, drivers of demand, and the intersection of sustainability and regulation that now shape commercial decisions. The molecule's versatility, from formulation-level functionality to intermediate synthesis, means that strategic choices made by producers and end users reverberate across supply chains and application sectors. As such, leadership teams require a concise, technically grounded brief to prioritize investments in capacity, feedstock strategy, and new product development.

In the sections that follow, stakeholders will find an integrated perspective that brings together application-level dynamics, feedstock and production considerations, policy impacts, and emergent innovation vectors. The aim is to equip executives with a clear view of competitive levers and risk factors without obfuscation by extraneous detail. Transitional takeaways emphasize operational resilience, sourcing agility, and the commercial implications of sustainability commitments. Readers should be prepared to translate these insights into targeted actions in procurement, regulatory affairs, and R&D pipeline planning.

This document is crafted for leaders who must balance short-term supply continuity with medium-term strategic repositioning, and it highlights the decision points that will unlock value or expose vulnerability in the evolving isobutyric acid landscape.

How sustainability-driven procurement, bio-based production advances, and tightening product specifications are reorganizing competitive advantage across the supply chain

The isobutyric acid landscape is undergoing transformative shifts driven by three converging forces: sustainability commitments by brand owners, feedstock innovation in green chemistry, and tighter regulatory scrutiny on purity and provenance. Corporates across applications increasingly demand lower-carbon inputs and transparent supply chains, prompting suppliers to invest in bio-based routes, lifecycle analysis, and certifiable traceability. At the same time, advances in catalytic conversion and fermentation platforms are reducing technical barriers to adoption of renewable feedstocks, although scale and cost parity remain practical hurdles.

Concurrently, formulation trends in adjacent sectors are elevating the technical expectations placed on suppliers; for example, end users in personal care and pharmaceuticals are specifying narrower impurity profiles and grade differentiation, which requires sharper process control and quality assurance. These demand-side pressures are catalyzing product innovation while also compressing supplier tolerance for quality variance. As a result, strategic partnerships between specialty chemical manufacturers, biotech providers, and contract manufacturing organizations are becoming more prevalent, enabling shared risk in process development and scale-up.

In sum, the landscape's transformation is incremental but systemic: sustainability-led procurement criteria, technological maturation of bio-based synthesis, and heightened product specification expectations are creating new competitive fault lines that redefine value creation for producers and buyers alike.

Evaluating the strategic supply chain responses, procurement shifts, and production realignments prompted by cumulative United States tariff actions in 2025

The cumulative impact of recent and prospective tariff measures in the United States has produced a set of measurable supply chain responses that extend beyond immediate price effects. Firms exposed to import duties have shifted sourcing strategies toward more diverse supplier bases, accelerated supplier qualification processes, and, where feasible, pursued nearshoring or regional manufacturing to insulate operations from trade-policy volatility. These adjustments have also encouraged longer-term contracts with domestic producers and strategic inventory management to reduce exposure to sudden cost volatility.

Downstream manufacturers in applications such as agrochemicals and pharmaceuticals have responded by revising procurement protocols and by increasing engagement with suppliers to secure guaranteed quality and delivery windows. The tariff environment has therefore elevated the commercial importance of supply continuity and traceability, which in turn incentivizes suppliers to demonstrate robust quality systems and logistical reliability. Furthermore, trade measures have influenced capital allocation for some manufacturers, prompting feasibility assessments of local unit expansions versus intensified collaboration with regional toll processors.

Although tariffs can create short-term cost pressures, they also catalyze structural shifts that favor suppliers capable of rapid qualification, consistent quality, and secure logistics. For corporate decision-makers, the imperative is to evaluate supplier resilience and to model procurement scenarios that internalize potential policy shifts, thereby converting tariff-driven disruption into a strategic impetus for supply chain robustness.

Granular segmentation reveals how application-specific specifications, production routes, grade differentiation, product forms, and distribution channels determine commercial and technical priorities

Segment-level analysis reveals differentiated value pools and operating requirements that manufacturers and buyers must navigate simultaneously. Based on application, demand spans agrochemicals where isobutyric acid serves as a key intermediate across fungicides, herbicides, and insecticides; food and beverage applications where it is used as an acidulant and a flavoring agent; personal care formulations leveraging emollient and fragrance functionalities; and pharmaceutical production where its role as a drug intermediate and excipient requires stringent quality regimes. These application pathways impose distinct purity, documentation, and logistics constraints that shape product specifications and commercial terms.

Based on source, supply is bifurcated between bio-based and synthetic production routes, each with unique capital intensity, feedstock exposure, and sustainability credentials. Choice of route affects lifecycle emissions, certification potential, and customer acceptance in sustainability-conscious markets. Based on grade, customers select between food grade, pharmaceutical grade, and technical grade, with pharmaceutical grade further segmented into EP grade, JP grade, and USP grade, and technical grade subdivided into industrial and research grades; these gradations determine manufacturing controls, quality management systems, and regulatory documentation requirements. Based on form, liquid and powder formats drive differences in transport economics, storage, and downstream blending operations. Based on distribution channel, sales occur via direct sales mechanisms such as company sales forces, distributors including retail and wholesale distributors, and online channels encompassing company websites and e-commerce platforms, each channel presenting distinct margin structures and customer engagement models.

Taken together, these segmentation dimensions define a complex commercial matrix. Producers must align route-to-market strategy with technical capabilities and certification investments, while buyers must prioritize supplier attributes according to application-critical requirements and distribution preferences. Transitional strategies that coordinate source, grade, and channel choices will yield the most durable commercial outcomes.

How regional regulatory expectations, feedstock availability, and demand profiles across Americas, EMEA, and Asia-Pacific are reshaping supply and compliance strategies

Regional dynamics shape supply, regulatory alignment, and end-user requirements in ways that materially affect strategic planning. In the Americas, manufacturing ecosystems benefit from proximity to large agrochemical and pharmaceutical clusters, as well as integrated logistics networks that support rapid product movement; however, trade policy and feedstock access can introduce variability that requires hedged sourcing strategies. Transitioning to lower-carbon production pathways has become a decision factor for many North American buyers, which in turn raises the premium for certified bio-based offerings.

In Europe, Middle East & Africa, regulatory rigor and consumer expectations often place a premium on documented sustainability and traceability, while geopolitical and energy considerations influence feedstock economics and manufacturing location choices. The EMEA region's regulatory heterogeneity compels suppliers to maintain flexible compliance frameworks and to invest in documentation that satisfies multiple jurisdictional standards.

In the Asia-Pacific region, capacity expansion and process innovation are driving supply-side competitiveness, with several producers leveraging lower-cost feedstocks and large-scale fermentation assets. At the same time, rising domestic demand for higher-purity grades-particularly for pharmaceuticals and personal care-has heightened upstream quality controls and testing infrastructure. Cross-region flows are therefore being reconfigured as buyers reconcile cost, lead time, and regulatory conformity, and as suppliers optimize footprint and service models to meet increasingly localized requirements.

Overall, region-specific strategies must reconcile local regulatory expectations, feedstock realities, and end-use demand profiles to achieve resilient commercial positioning.

Competitive advantage emerges for producers who combine technical rigor, flexible commercial channels, and collaborative production models to capture specification-driven demand

Competitive dynamics in the isobutyric acid value chain are characterized by a mix of specialty chemical manufacturers, vertically integrated producers, and smaller innovators focused on bio-based routes and process intensification. Leaders differentiate through investments in quality systems that enable supply to regulated sectors such as pharmaceuticals and food, while challengers often compete on cost, feedstock integration, or niche application expertise. Strategic partnerships and tolling arrangements have become frequent tools to manage capacity constraints, share technical risk, and accelerate time-to-market for new production processes.

Innovation pipelines are concentrating on enzymatic and fermentation-based processes, process intensification techniques to reduce impurity formation, and downstream formulation support that eases customer qualification. Companies that develop robust analytical capabilities and demonstrate transparent lifecycle attributes gain preferential access to procurement programs that prioritize sustainability. Meanwhile, firms that maintain flexible distribution channels-combining direct sales for large-volume industrial customers with distributor and e-commerce options for regional and specialty demand-tend to achieve deeper market penetration without disproportionately expanding fixed assets.

For management teams, the implication is clear: competitive advantage accrues to those who combine technical rigor with agile commercial models. Investments in quality, traceability, and collaborative production arrangements will determine which suppliers capture higher-margin, specification-driven business in the near term.

Actionable steps for executives to enhance supplier resilience, accelerate bio-based adoption, upgrade regulatory capabilities, and optimize distribution and procurement planning

Industry leaders should prioritize a series of pragmatic actions to convert emerging risks into strategic opportunities. The first priority is to codify supplier resilience criteria that incorporate quality systems, traceability, and logistic redundancy; procurement teams must move beyond price-centric metrics to include these attributes in contract terms and qualification processes. Secondly, targeted investment in pilot-scale bio-based production or partnerships with biotech firms can create credible sustainability credentials and reduce long-term feedstock exposure, while allowing firms to manage capital deployment against technical validation milestones.

Thirdly, companies serving regulated markets should strengthen analytical and regulatory affairs capabilities to expedite grade qualification across EP, JP, and USP requirements; this capability reduces time-to-supply and enhances customer trust. Fourthly, adopt flexible distribution models that blend direct sales for strategic accounts with distributor and online channels for specialized or regional demand, thereby optimizing reach without excessive fixed-cost expansion. Fifthly, incorporate scenario-based procurement planning that models tariff and trade-policy changes, enabling proactive nearshoring or contract restructuring when geopolitical risk intensifies.

Finally, embed cross-functional programs that align R&D, quality, and commercial teams to ensure that product development reflects downstream formulation needs and procurement realities. Executed together, these actions create a resilient, market-responsive capability set that protects margins and supports growth in specification-driven segments.

A rigorous mixed-methods approach blending primary interviews, technical review, supply chain mapping, and scenario analysis to underpin actionable strategic conclusions

The research approach underpinning this executive summary combined multi-disciplinary inputs to ensure balanced, verifiable insights. Primary research included structured interviews with technical leaders across formulation, procurement, and manufacturing functions, alongside discussions with process engineers and regulatory specialists to validate production route trade-offs and grade-specific requirements. These engagements provided qualitative depth on operational constraints, qualification timelines, and customer acceptance criteria.

Secondary analysis drew on peer-reviewed literature, patent filings, regulatory guidance documents, and public technical disclosures to triangulate production-route characteristics, lifecycle implications, and quality testing methodologies. Supply chain mapping exercises identified critical nodes and logistical chokepoints, while scenario analysis explored the practical implications of trade-policy shifts and feedstock volatility on procurement decision-making. Where appropriate, case studies of process-scale deployments and commercial partnerships were used to illustrate successful approaches to capacity scaling and market entry.

Analytical rigor was maintained through cross-validation of interview findings with technical documentation and regulatory standards. The objective methodology prioritized reproducibility and clarity, enabling readers to understand the evidentiary basis for each strategic conclusion and to adapt the approach to firm-specific inquiries or deeper due-diligence tasks.

A strategic synthesis of technical, regulatory, and commercial imperatives that charts a resilient path for producers and buyers in an evolving isobutyric acid landscape

In conclusion, isobutyric acid occupies a strategic node where chemistry, sustainability, and regulatory requirements intersect, creating both opportunities and operational challenges for producers and buyers. The combination of evolving demand for higher-purity grades, growing interest in bio-based production routes, and externally driven trade-policy dynamics necessitates a re-evaluation of procurement criteria, capacity investment, and partnership strategies. Firms that proactively align technical capabilities with distribution flexibility and robust quality systems will be better positioned to capture specification-driven value.

Moreover, the tariff environment and regional differences in regulation and feedstock economics underscore the importance of supply chain diversification and scenario planning. Executives should treat current disruptions as catalysts for long-term capability building rather than transient obstacles. By embedding the recommended steps-strengthening qualification processes, investing selectively in bio-based pathways, and aligning commercial channels with customer needs-organizations can convert near-term risk into durable competitive differentiation.

The path forward requires coordinated action across R&D, quality, procurement, and commercial teams to ensure that product development and supply strategies respond to application-specific demands while remaining resilient to policy and market volatility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Isobutyric Acid Market, by Source

  • 8.1. Bio-Based
  • 8.2. Synthetic

9. Isobutyric Acid Market, by Grade

  • 9.1. Food Grade
  • 9.2. Pharmaceutical Grade
    • 9.2.1. EP Grade
    • 9.2.2. JP Grade
    • 9.2.3. USP Grade
  • 9.3. Technical Grade
    • 9.3.1. Industrial Grade
    • 9.3.2. Research Grade

10. Isobutyric Acid Market, by Form

  • 10.1. Liquid
  • 10.2. Powder

11. Isobutyric Acid Market, by Application

  • 11.1. Agrochemicals
    • 11.1.1. Fungicides
    • 11.1.2. Herbicides
    • 11.1.3. Insecticides
  • 11.2. Food And Beverage
    • 11.2.1. Acidulants
    • 11.2.2. Flavoring Agents
  • 11.3. Personal Care
    • 11.3.1. Emollients
    • 11.3.2. Fragrances
  • 11.4. Pharmaceuticals
    • 11.4.1. Drug Intermediates
    • 11.4.2. Excipients

12. Isobutyric Acid Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Retail Distributors
    • 12.2.2. Wholesale Distributors
  • 12.3. Online Channels
    • 12.3.1. Company Website
    • 12.3.2. E-Commerce Platforms

13. Isobutyric Acid Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Isobutyric Acid Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Isobutyric Acid Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Isobutyric Acid Market

17. China Isobutyric Acid Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AFYREN S.A.
  • 18.6. Arkema Group
  • 18.7. BASF SE
  • 18.8. Central Drug House
  • 18.9. Chemos GmbH
  • 18.10. Daicel Corporation
  • 18.11. Dow Inc.
  • 18.12. Eastman Chemical Company
  • 18.13. Evonik Industries AG
  • 18.14. Glentham Life Sciences Limited
  • 18.15. INEOS Group Limited
  • 18.16. Jiangsu Dynamic Chemical Co., Ltd.
  • 18.17. Lygos, Inc.
  • 18.18. LyondellBasell Industries N.V.
  • 18.19. Merck KGaA
  • 18.20. Mitsubishi Chemical Corporation
  • 18.21. Nanjing Chemical Material Corporation
  • 18.22. Perstorp Holding AB
  • 18.23. Sasol Limited
  • 18.24. Shanghai Aladdin Biochemical Technology Co., Ltd.
  • 18.25. Sigma-Aldrich Corporation
  • 18.26. Snowco Industrial Co., Ltd.
  • 18.27. Tokyo Chemical Industry Co., Ltd.
  • 18.28. Wacker Chemie AG
  • 18.29. Weifang Qiyi Chemical Co., Ltd.
  • 18.30. Yufeng International Group Co., Ltd.
  • 18.31. Zhejiang Funai Pharmaceutical Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL ISOBUTYRIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ISOBUTYRIC ACID MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ISOBUTYRIC ACID MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ISOBUTYRIC ACID MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ISOBUTYRIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY BIO-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY BIO-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY BIO-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EP GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EP GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EP GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY JP GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY JP GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY JP GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY USP GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY USP GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY USP GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY RESEARCH GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY RESEARCH GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FUNGICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FUNGICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FUNGICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY HERBICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY HERBICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY HERBICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY INSECTICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY INSECTICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY INSECTICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ACIDULANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ACIDULANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ACIDULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FLAVORING AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FLAVORING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FLAVORING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EMOLLIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EMOLLIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EMOLLIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FRAGRANCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FRAGRANCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY FRAGRANCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DRUG INTERMEDIATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DRUG INTERMEDIATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DRUG INTERMEDIATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EXCIPIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EXCIPIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY EXCIPIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY RETAIL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY RETAIL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY RETAIL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 239. GCC ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GCC ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 244. GCC ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 245. GCC ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. GCC ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 248. GCC ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. GCC ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 281. G7 ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. G7 ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 287. G7 ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. G7 ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 290. G7 ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. G7 ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 295. NATO ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 296. NATO ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 300. NATO ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 301. NATO ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. NATO ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 304. NATO ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 306. NATO ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. NATO ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 308. NATO ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL ISOBUTYRIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA ISOBUTYRIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA ISOBUTYRIC ACID MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA ISOBUTYRIC ACID MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA ISOBUTYRIC ACID MARKET SIZE, BY TECHNICAL GRADE, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA ISOBUTYRIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA ISOBUTYRIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA ISOBUTYRIC ACID MARKET SIZE, BY AGROCHEMICALS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA ISOBUTYRIC ACID MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA ISOBUTYRIC ACID MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA ISOBUTYRIC ACID MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 335. CHINA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. CHINA ISOBUTYRIC ACID MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 337. CHINA ISOBUTYRIC ACID MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)